interferoninduc
transmembran
ifitm
protein
inhibit
wide
rang
virus
previous
report
inhibit
human
immunodefici
viru
type
strain
human
unknown
whether
strain
similarli
inhibit
ifitm
whether
exist
viral
countermeasur
overcom
ifitm
inhibit
report
strain
restrict
viral
envelop
glycoprotein
partli
respons
insensit
howev
profoundli
inhibit
mutant
known
delet
amino
acid
cterminu
contrast
wild
type
affect
entri
mutant
diminish
entri
inhibit
correl
predomin
local
plasma
membran
entri
occur
spite
strong
conserv
among
speci
mous
amino
acid
shorter
cterminu
compar
human
like
human
mutant
mous
also
inhibit
entri
first
report
illustr
role
viral
envelop
protein
overcom
restrict
result
also
demonstr
import
ctermin
region
modul
antivir
function
control
protein
subcellular
local
interferon
inhibit
viru
infect
induc
express
hundr
host
gene
known
interferonstimul
gene
isg
encod
antivir
effector
among
antivir
protein
small
protein
famili
call
interferoninduc
transmembran
ifitm
protein
ifitm
averag
length
amino
acid
contain
two
predict
transmembran
domain
conserv
intracellular
domain
although
shown
modestli
inhibit
vesicular
stomat
viru
vsv
hepat
c
viru
hcv
decad
ago
antivir
function
establish
potent
restrict
influenza
viru
west
nile
viru
dengu
viru
report
genomewid
function
screen
subsequ
studi
reveal
mani
virus
suscept
ifitm
restrict
includ
flavivirus
west
nile
viru
dengu
viru
yellow
fever
viru
filovirus
marburg
viru
ebola
viru
sar
coronaviru
reoviru
rift
valley
fever
viru
human
immunodefici
viru
type
jaagsiekt
sheep
retroviru
jsrv
other
review
vivo
import
ifitm
protein
antivir
defens
support
protect
mice
influenza
viru
infect
support
singl
nucleotid
polymorph
gene
shown
associ
pathogenesi
sever
influenza
viru
infect
human
human
five
ifitm
gene
includ
cluster
within
region
chromosom
except
locat
mb
downstream
calciumbind
domain
ctermin
region
involv
bone
miner
matur
thu
also
name
bone
restrict
ifitmlik
protein
bril
express
varieti
tissu
express
stimul
type
type
ii
interferon
due
presenc
interferon
stimul
respons
element
isr
promot
addit
role
antivir
defens
also
report
particip
antiprolif
signal
cell
adhes
oncogenesi
review
instanc
express
three
ifitm
member
significantli
upregul
colorect
tumor
cell
concurr
activ
wntbetacatenin
signal
pathway
function
unknown
except
conserv
among
ifitm
protein
across
mani
eukaryot
speci
protein
differ
abil
inhibit
differ
virus
exampl
inhibit
influenza
viru
potent
inhibit
marburg
ebola
virus
contrast
latter
two
virus
strongli
inhibit
inhibit
rift
valley
fever
viru
differ
restrict
profil
like
result
sequenc
diverg
share
higher
sequenc
homolog
studi
report
human
differenti
affect
replic
two
close
relat
strain
viral
envelop
glycoprotein
respons
differenti
sensit
restrict
interestingli
delet
ctermin
sequenc
allow
mutant
potent
inhibit
virus
highlight
import
role
ctermin
domain
regul
antivir
function
human
inhibit
replic
previous
shown
inhibit
replic
strain
cell
test
anoth
strain
call
exhibit
inhibitori
effect
fig
contrast
mark
suppress
replic
fig
observ
confirm
resist
deriv
viru
call
fig
human
rel
long
ctermin
region
previous
show
mutant
lack
ctermin
sequenc
still
strongli
inhibit
fig
given
resist
wild
type
human
expect
would
also
refractori
cterminu
truncat
surprisingli
mutant
strongli
inhibit
replic
fig
data
suggest
ctermin
sequenc
neg
modul
function
delet
ctermin
sequenc
lead
inhibit
entri
previous
shown
contrast
human
affect
entri
similarli
inhibitori
effect
entri
observ
fig
interestingli
ctermin
truncat
mutant
diminish
entri
fig
inhibit
appear
specif
sinc
neither
wt
ctermin
truncat
affect
entri
mediat
g
protein
vesicular
stomat
viru
vsv
fig
order
understand
ctermin
sequenc
might
regul
abil
impair
entri
examin
cellular
local
ctermin
delet
mutant
immunofluoresc
confoc
microscopi
wild
type
exhibit
predomin
intracellular
distribut
show
coloc
earli
endosom
marker
fig
remov
last
amino
acid
ctermin
sequenc
reloc
major
cell
peripheri
fig
indic
cterminu
truncat
mutant
mostli
posit
plasma
membran
entri
occur
also
noteworthi
delet
mutant
exhibit
intracellular
local
similar
wild
type
fig
yet
markedli
diminish
entri
fig
suggest
mutant
may
employ
distinct
mechan
deter
entri
next
ask
ctermin
sequenc
modul
protein
subcellular
distribut
appar
endocyt
sort
signal
present
within
sequenc
delet
one
possibl
sequenc
may
serv
retent
signal
sequest
endoplasm
reticulum
er
golgi
hypothesi
refut
result
show
block
endocytosi
dynamin
inhibitor
dynasor
caus
reloc
plasma
membran
oppos
variant
er
retent
signal
kdel
insert
cterminu
exhibit
er
local
even
presenc
dynasor
fig
data
suggest
endocyt
protein
remov
ctermin
sequenc
caus
reloc
plasma
membran
interfer
entri
mous
diminish
entri
ortholog
differ
speci
highli
conserv
except
mous
rat
shorten
ctermini
fig
two
protein
amino
acid
shorter
ctermini
compar
human
prompt
us
test
whether
would
act
like
ctermin
truncat
human
inhibit
delet
mutat
indic
wild
type
mutat
flag
tag
attach
nterminu
level
wild
type
mutat
stabli
transduc
cell
examin
western
blot
amount
doxycyclin
use
induc
express
level
tubulin
probe
intern
control
c
replic
cell
stabli
express
mutant
viru
product
determin
measur
level
viral
rt
activ
cultur
supernat
repres
result
three
independ
infect
shown
fig
show
mous
suppress
replic
cell
mous
markedli
decreas
entri
entri
mediat
vsv
g
protein
fig
data
highlight
import
ctermin
sequenc
modul
antivir
function
also
suggest
greater
antivir
potenti
mous
next
perform
mutagenesi
identifi
viral
protein
account
resist
human
end
gener
chimer
virus
exchang
dna
fragment
test
viral
dna
fragment
bear
genet
inform
determin
resist
fig
result
show
exchang
dna
fragment
locat
sali
restrict
site
call
sb
fragment
allow
bh
sb
resist
reciproc
nl
sb
sensit
inhibit
fig
sb
dna
fragment
encod
four
viral
protein
tat
rev
vpu
env
determin
viral
protein
play
counter
role
exchang
env
sequenc
result
infect
experi
show
env
enabl
replic
cell
wherea
insert
env
dramat
reduc
viru
replic
presenc
fig
support
role
env
overcom
inhibit
signific
effect
regard
observ
small
dna
fragment
locat
sali
site
begin
env
fig
effici
celltocel
transmiss
one
mechan
behind
inhibit
reduct
level
infect
cell
well
diminut
viru
product
fig
similar
defect
also
observ
infect
cell
fig
indic
escap
spread
infect
without
need
restor
decreas
express
recent
report
becam
resist
restrict
spread
infect
acquir
mutat
viral
env
vpu
protein
togeth
enhanc
viru
transmiss
cell
order
test
whether
mechan
support
resist
compar
celltocel
transmiss
effici
inde
effici
transmit
cell
fig
phenotyp
readili
revers
env
sequenc
exchang
either
exchang
sb
fragment
env
sequenc
alon
fig
similar
observ
made
viru
transmiss
control
cell
cell
express
fig
collect
data
suggest
env
protein
mediat
greater
celltocel
transmiss
properti
may
allow
escap
inhibit
viru
spread
infect
condit
transfect
plasmid
dna
express
wild
type
variant
er
retent
signal
attach
cterminu
cell
either
treat
dynasor
dmso
control
detect
immunostain
antiflag
antibodi
endogen
calreticulin
stain
anticalreticulin
antibodi
nuclei
stain
dapi
imag
shown
repres
major
subcellular
distribut
protein
studi
base
observ
two
close
relat
subtyp
b
strain
differenti
inhibit
human
viru
spread
infect
find
allow
us
identifi
viral
compon
gave
rise
resist
result
mutagenesi
viru
replic
studi
reveal
essenti
role
viral
env
protein
evas
exchang
env
sequenc
revers
suscept
parent
strain
inhibit
role
env
protein
determin
viral
sensit
corrobor
recent
report
show
abl
develop
resist
mutat
env
vpu
preced
illumin
function
viral
env
overcom
host
restrict
one
exampl
env
antagon
tetherin
addit
env
shown
regul
establish
latent
infect
rest
cell
like
modul
function
certain
cellular
pathway
case
remain
determin
whether
env
serv
viral
target
env
act
viral
antagonist
counter
although
affect
entri
either
product
virus
diminish
oneround
infect
assay
allud
inhibit
postentri
step
infect
surpris
spite
inhibit
similar
degre
oneround
infect
assay
crippl
longterm
viru
replic
assay
fig
seemingli
conflict
observ
could
reconcil
major
differ
oneround
infect
longterm
infect
ie
latter
infect
mode
involv
viru
celltocel
transmiss
actual
domin
transmiss
infect
free
viru
particl
thu
possibl
superior
replic
cell
despit
virus
equal
impair
oneround
infect
might
result
greater
abil
transmit
cell
inde
found
effici
transmiss
cell
cell
therefor
util
strong
celltocel
transmiss
compens
defici
viru
product
caus
effici
celltocel
transmiss
determin
viral
env
protein
insert
env
sequenc
diminish
celltocel
transmiss
parent
viru
reciproc
env
protein
increas
celltocel
transmiss
concurr
chang
celltocel
transmiss
exchang
env
sequenc
also
switch
sensit
human
one
possibl
scenario
env
protein
may
modul
viru
sensit
human
restrict
virtu
abil
mediat
regul
viru
celltocel
transmiss
env
sequenc
differ
amino
acid
posit
chang
amino
acid
env
counterpart
increas
resist
human
data
shown
conceiv
two
amino
acid
env
requir
gener
resist
human
affect
entri
either
fig
interestingli
gain
abil
inhibit
entri
ctermin
sequenc
truncat
fig
agreement
observ
ctermin
truncat
enhanc
abil
promot
infect
coronaviru
gain
function
appear
viru
specif
sinc
truncat
affect
viru
entri
mediat
vsv
g
protein
fig
one
possibl
explan
differenti
inhibit
vsv
adopt
differ
pathway
entri
entri
phindepend
occur
plasma
membran
wherea
vsv
enter
cell
endosom
low
ph
support
scenario
remov
last
amino
acid
cterminu
human
reloc
protein
intracellular
site
cell
peripheri
fig
cellular
locationdepend
inhibit
phenomenon
previous
report
delet
endocyt
sort
signal
led
redistribut
plasma
membran
consequ
loss
inhibit
influenza
viru
entri
take
place
late
endosom
addit
regul
sequenc
subcellular
distribut
ifitm
also
modul
factor
exampl
compar
intracellular
local
cell
shown
studi
exogen
observ
plasma
membran
cell
addit
cell
typedepend
effect
factor
includ
express
level
treatment
interferon
may
also
affect
ifitm
protein
local
cell
unclear
ctermin
sequenc
modul
subcellular
distribut
especi
light
recent
report
show
ctermin
domain
extracellular
one
mechan
extracellularlumin
protein
domain
regul
protein
subcellular
local
erlumin
retent
signal
data
rule
presenc
erlumin
retent
signal
within
ctermin
region
inhibit
endocytosi
dynamin
inhibitor
dynasor
redistribut
plasma
membran
treatment
fail
variant
exogen
er
retent
signal
insert
cterminu
fig
altern
delet
ctermin
sequenc
may
chang
membran
topolog
result
disturb
subcellular
local
remain
determin
strain
also
differenti
inhibit
human
suspect
chanc
find
human
strain
either
labadapt
naturallyexist
circul
would
low
exert
select
pressur
vivo
replic
sinc
strain
propag
cultur
human
cell
line
adapt
vitro
cultur
condit
result
could
lost
origin
viral
sequenc
confer
resist
may
happen
envis
sinc
never
encount
mous
strain
would
sensit
mous
inhibit
work
ongo
examin
effect
ifitm
protein
differ
speci
strain
hiv
differ
lentivirus
provir
dna
clone
obtain
nih
aid
research
refer
reagent
program
dna
deriv
dna
similar
except
insert
stop
codon
begin
env
gene
therefor
envneg
gift
stephen
ferguson
michel
tremblay
dna
construct
cdna
human
gene
insert
pretroxtightpur
vector
mutant
differ
length
ctermin
sequenc
illustr
fig
previous
report
er
retent
signal
kdel
ad
cterminu
pcrbase
method
cdna
clone
mous
purchas
atcc
amplifi
pcr
clone
pretroxtightpur
gener
like
human
construct
flag
tag
ad
nterminu
facilit
detect
western
blot
dna
clone
verifi
sequenc
antiflag
antibodi
purchas
sigma
antitubulin
antibodi
santa
cruz
biotechnolog
fitcconjug
antibodi
beckman
anticalreticulin
antibodi
abcam
bmqc
invitrogen
cell
cell
origin
obtain
atcc
human
cell
line
cultur
medium
supplement
fetal
bovin
serum
fb
mm
lglutamin
u
penicillinml
streptomycinml
order
stabli
transduc
cell
first
prepar
retroviru
stock
transfect
packag
cell
clontech
pretroxtightpur
vector
togeth
pcmvvsvg
plasmid
express
g
protein
vesicular
stomat
viru
vsv
virus
use
infect
cell
togeth
anoth
retroviru
carri
rtta
activ
gene
clontech
infect
cell
cultur
medium
supplement
tetracyclinefre
fb
clontech
puromycinml
mg
select
stabli
transduc
cell
stock
produc
transfect
human
embryon
kidney
cell
provir
dna
clone
use
invitrogen
cultur
supernat
clarifi
centrifug
rpm
beckman
benchtop
centrifug
min
virus
aliquot
use
immedi
store
futur
use
amount
virus
determin
measur
viral
ca
elisa
cell
stabli
transduc
tetifitm
retrovir
vector
treat
doxycyclin
mgml
exposur
equival
ng
viral
ca
per
cell
viru
growth
monitor
measur
viral
revers
transcriptas
activ
supernat
differ
time
interv
experi
perform
describ
briefli
two
viru
stock
first
produc
transfect
cell
use
either
provir
dna
dna
env
pcmvvsvg
dna
togeth
pcmvblamvpr
viru
stock
name
blamvpr
envelop
protein
vsvg
protein
envelop
respect
amount
virus
stock
determin
measur
viral
ca
elisa
cell
line
first
treat
doxycylin
mgml
hour
infect
either
amount
equival
ng
viral
ca
vsvgblamvpr
amount
equival
ng
viral
ca
spinnocul
x
g
min
room
temperatur
follow
incub
cell
wash
twice
co
independ
medium
incub
load
solut
room
temperatur
one
hour
load
solut
contain
nm
acet
acid
contain
mgml
ml
co
independ
medium
wash
develop
media
contain
probenecid
mm
tetracyclinefre
fb
ml
co
independ
medium
invitrogen
cell
kept
dark
room
temperatur
hour
fix
paraformaldehyd
analyz
flow
cytometri
first
cell
infect
particl
bear
vsvg
protein
enhanc
infect
effici
forti
hour
post
infect
infect
cell
design
donor
cell
wash
complet
medium
mix
equal
number
uninfect
cell
design
target
cell
label
cell
tracker
bmqc
invitrogen
hour
cell
mixtur
fix
paraformaldehyd
permeabil
triton
stain
fitcconjug
antibodi
donor
target
cell
score
flow
cytometri
cell
seed
onto
polylysineco
coverslip
transfect
indic
dna
construct
cell
fix
paraformaldehyd
phosphat
buffer
salin
min
room
temperatur
permeabil
triton
min
incub
block
buffer
contain
bsa
skim
milk
cell
stain
indic
primari
antibodi
dilut
hour
room
temperatur
follow
stain
fitc
tritc
conjug
secondari
antibodi
dilut
nuclei
stain
dapi
dynasor
treatment
perform
incub
cell
dynasor
hour
prior
fixat
imag
acquir
leica
tc
laser
scan
confoc
microscop
use
object
sequentialacquisit
set
imag
obtain
use
laser
power
digit
gain
satur
resolut
x
pixel
bit
imagej
softwar
use
postacquisit
measur
fluoresc
intens
support
inform
fig
effect
replic
cell
treat
doxcycylin
induc
express
expos
viru
product
determin
measur
viral
revers
transcriptas
activ
cultur
supernat
variou
time
interv
ep
conceiv
design
experi
cl
wq
perform
experi
rj
sd
qp
analyz
data
rj
sd
sll
cl
contribut
reagentsmaterialsanalysi
tool
sll
cl
wrote
paper
sll
wq
cl
